PD 173074
-
Catalog number1675-100
-
PricePlease ask
-
Size100 mg
-
-
Alternative_nameN-[2-[[4-(Diethylamino)butyl]amino]-6-(3,5-dimethoxyphenyl)pyrido[2,3-d]pyrimidin-7-yl]-N’-(1,1-dimethylethyl)urea
-
DescriptionA potent and selective FGFR1 tyrosine kinase inhibitor (IC₅₀ = 21.5 nM). Blocking of the FGFR signaling pathway by PD 173074 leads to self-renewal of stem cells via ERK1/2 activation. Treatment of FGF2-expressing human multipotent adipose-derived stem cells with PD173074 decreases dramatically their clonogenicity and differentiation potential.
-
CAS Number219580-11-7
-
Structure AvailableYes
-
Salt FormNo
-
Molecular FormulaC₂₈H₄₁N₇O₃
-
Molecular Weight523.67
-
Cell PermeableYes
-
Purity≥98% by TLC
-
SolubilitiesDMSO (10 mg/ml)
-
HandlingProtect from air and light
-
Tag LineA FGFR1 kinase inhibitor
-
Storage Condition-20°C
-
Shipping Conditiongel pack
-
Shelf Life24 months
-
MDL NumberMFCD11045982
-
PubChem CID1401
-
SMILESCCN(CC)CCCCNC1=NC2=NC(=C(C=C2C=N1)C3=CC(=CC(=C3)OC)OC)NC(=O)NC(C)(C)C
-
InChiInChI=1S/C28H41N7O3/c1-8-35(9-2)13-11-10-12-29-26-30-18-20-16-23(19-14-21(37-6)17-22(15-19)38-7)25(31-24(20)32-26)33-27(36)34-28(3,4)5/h14-18H,8-13H2,1-7H3,(H3,29,30,31,32,33,34,36)
-
InChi KeyDXCUKNQANPLTEJ-UHFFFAOYSA-N
-
MSDS AvailableYes
-
Gene target
-
Short namePD 173074
-
Alternative namePD 173074
-